AAAAAA

   
Results: 1-12 |
Results: 12
POTENT SUPPRESSION OF HIV-1 REPLICATION IN HUMANS BY T-20, A PEPTIDE INHIBITOR OF GP41-MEDIATED VIRUS ENTRY
Authors: KILBY JM HOPKINS S VENETTA TM DIMASSIMO B CLOUD GA LEE JY ALLDREDGE L HUNTER E LAMBERT D BOLOGNESI D MATHEWS T JOHNSON MR NOWAK MA SHAW GM SAAG MS
Citation: Jm. Kilby et al., POTENT SUPPRESSION OF HIV-1 REPLICATION IN HUMANS BY T-20, A PEPTIDE INHIBITOR OF GP41-MEDIATED VIRUS ENTRY, Nature medicine, 4(11), 1998, pp. 1302-1307
VACCINES AGAINST ANIMAL AND HUMAN LENTIRETROVIRUSES
Authors: BOLOGNESI D
Citation: D. Bolognesi, VACCINES AGAINST ANIMAL AND HUMAN LENTIRETROVIRUSES, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 224-224
STUDIES ON HIV-1 VACCINES BY THE AIDS VACCINE EVALUATION GROUP (AVEG)
Authors: BELSHE RB BOLOGNESI D CLEMENTS ML COREY L FAST P GRAHAM B KEEFER M MESTECKY J MULLIGAN M
Citation: Rb. Belshe et al., STUDIES ON HIV-1 VACCINES BY THE AIDS VACCINE EVALUATION GROUP (AVEG), AIDS research and human retroviruses, 11, 1995, pp. 138-138
HIV-1 RECOMBINANT GP160 VACCINE-INDUCED ANTIBODIES IN SERUM AND SALIVA
Authors: GORSE GJ ROGERS JH PERRY JE NEWMAN FK FREY SE PATEL GB BELSHE RB SCHWARTZ DH CLEMENTS ML KEEFER M DOLIN R MCELRATH J COREY L GRAHAM BS WRIGHT PF STABLEIN DM MATTHEWS TJ BOLOGNESI D MESTECKY J WALKER MC FAST PE
Citation: Gj. Gorse et al., HIV-1 RECOMBINANT GP160 VACCINE-INDUCED ANTIBODIES IN SERUM AND SALIVA, Vaccine, 13(2), 1995, pp. 209-214
SEROLOGICAL REACTIVITY FROM HIV-1 VACCINE RECIPIENTS PARTICIPATING INTHE AIDS VACCINE CLINICAL-TRIALS NETWORK
Authors: MATTHEWS T MCDANAL C GREENWELL T STREILEIN A DAVISON D RULAND M BOLOGNESI D BRADAC J WALKER MC
Citation: T. Matthews et al., SEROLOGICAL REACTIVITY FROM HIV-1 VACCINE RECIPIENTS PARTICIPATING INTHE AIDS VACCINE CLINICAL-TRIALS NETWORK, AIDS research and human retroviruses, 10, 1994, pp. 190000055-190000055
VACCINE-INDUCED ANTIBODIES TO NATIVE AND RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS
Authors: GORSE GJ FREY SE PATEL G NEWMAN FK BELSHE RB SCHWARTZ D CLEMENTS ML KEEFER M ROBERTS N DOLIN R MCELRATH J COREY L GRAHAM BS WRIGHT P MATTHEWS T BOLOGNESI D WALKER MC FAST P FERNIE BF
Citation: Gj. Gorse et al., VACCINE-INDUCED ANTIBODIES TO NATIVE AND RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS, Vaccine, 12(10), 1994, pp. 912-918
A PEPTIDE INHIBITOR OF HIV-1 REPLICATION - CORRELATION BETWEEN SOLUTION STRUCTURE AND VIRAL INHIBITION
Authors: WILD C OAS T MCDANAL C BOLOGNESI D MATTHEWS T
Citation: C. Wild et al., A PEPTIDE INHIBITOR OF HIV-1 REPLICATION - CORRELATION BETWEEN SOLUTION STRUCTURE AND VIRAL INHIBITION, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 675-675
IMMUNOLOGICAL RESPONSES IN HIV-SERONEGATIVE VOLUNTEERS TO LIVE RECOMBINANT AND SUBUNIT HIV-1 ENVELOPE VACCINES
Authors: CLEMENTS ML GRAHAM B BELSHE R DOLIN R COREY L FAST P STABLEIN D SILICIANO R BOLOGNESI D WRIGHT P GORSE G KEEFER M SCHWARTZ D MCELRATH J MATTHEWS T
Citation: Ml. Clements et al., IMMUNOLOGICAL RESPONSES IN HIV-SERONEGATIVE VOLUNTEERS TO LIVE RECOMBINANT AND SUBUNIT HIV-1 ENVELOPE VACCINES, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 682-682
AIDS - PRIMARILY A VIRAL OR AN AUTOIMMUNE-DISEASE
Authors: BOLOGNESI D
Citation: D. Bolognesi, AIDS - PRIMARILY A VIRAL OR AN AUTOIMMUNE-DISEASE, AIDS research and human retroviruses, 9(5), 1993, pp. 489-489
SAFETY AND IMMUNOGENICITY OF GENENTECH-IIIB RGP 120 HIV-1/
Authors: SCHWARTZ D CLEMENTS ML HOPKINS J BERMAN P DULIEGE AM TWADELL T AMMANN A BELSHE R GORSE G MATTHEWS T BOLOGNESI D FAST P SPOSTO R STABLEIN D
Citation: D. Schwartz et al., SAFETY AND IMMUNOGENICITY OF GENENTECH-IIIB RGP 120 HIV-1/, AIDS research and human retroviruses, 9, 1993, pp. 190000112-190000112
SAFETY AND IMMUNOGENICITY OF LAMBDA-BACULOVIRUS DERIVED HIV-1 IIIB RECOMBINANT GP160 VACCINE (VAXSYN(R)) IN HUMANS
Authors: KEEFER M BELSHE R CLEMENTS M GRAHAM B COREY L BOLOGNESI D STABLEIN D FAST P MONTEFIORI D SMITH G DOLIN R
Citation: M. Keefer et al., SAFETY AND IMMUNOGENICITY OF LAMBDA-BACULOVIRUS DERIVED HIV-1 IIIB RECOMBINANT GP160 VACCINE (VAXSYN(R)) IN HUMANS, AIDS research and human retroviruses, 9, 1993, pp. 190000113-190000113
SAFETY AND IMMUNOGENICITY OF FULLY GLYCOSYLATED RGP160 III, VACCINE IN LOW-RISK VOLUNTEERS
Authors: BELSHE RB CLEMENTS ML DOLIN R COREY L GRAHAM B BOLOGNESI D STABLEIN D EIBL K FAST P
Citation: Rb. Belshe et al., SAFETY AND IMMUNOGENICITY OF FULLY GLYCOSYLATED RGP160 III, VACCINE IN LOW-RISK VOLUNTEERS, AIDS research and human retroviruses, 9, 1993, pp. 190000113-190000113
Risultati: 1-12 |